Literature DB >> 11244151

Treatment histories of borderline inpatients.

M C Zanarini1, F R Frankenburg, G S Khera, J Bleichmar.   

Abstract

In this study, we describe the types and amounts of psychiatric treatment received by a well-defined sample of borderline personality disorder (BPD) inpatients, and compare these parameters with those of a group of carefully diagnosed personality-disordered controls. Finally, we assess the risk factors associated with a history of intensive, high-cost treatment, which we defined as having had two or more prior psychiatric hospitalizations. The treatment histories of 290 borderline inpatients and 72 axis II controls were assessed using a reliable semistructured interview. All nine forms of treatment studied except electroconvulsive therapy (ECT) were common among borderline patients (36% to 96%). In addition, a significantly higher percentage of borderline patients than axis II controls reported a history of individual and group therapy, day and residential treatment, psychiatric hospitalization, participating in self-help groups, and taking standing medications. They were also significantly younger when they first entered individual therapy and began to take standing medications. In addition, borderline patients spent more time than axis II controls in individual therapy and psychiatric hospitals, and were on standing medications for a significantly longer period of time. They also reported a significantly higher number of psychiatric hospitalizations, lifetime number of standing medications, and number of psychotropic medications taken at the same time. In addition, we found a highly significant multivariate predictive model for multiple prior hospitalizations. The six significant predictors were age 26 or older, a history of quasi psychotic thought, lifetime number of self-mutilative efforts and suicide attempts, a childhood history of reported sexual abuse, and an adult history of being physically and/or sexually assaulted. Taken together, these results confirm clinical impressions concerning the high rates of mental health services used by borderline patients. They also suggest that particularly high rates of costly inpatient treatment are associated with a complex admixture of older age, BPD symptoms in the cognitive and impulse realms, and traumatic life experiences occurring in both childhood and adulthood. Copyright 2001 by W.B. Saunders Company

Entities:  

Mesh:

Year:  2001        PMID: 11244151     DOI: 10.1053/comp.2001.19749

Source DB:  PubMed          Journal:  Compr Psychiatry        ISSN: 0010-440X            Impact factor:   3.735


  56 in total

Review 1.  Update on pharmacotherapy of borderline personality disorder.

Authors:  Mary C Zanarini
Journal:  Curr Psychiatry Rep       Date:  2004-02       Impact factor: 5.285

Review 2.  Psychopharmacology of borderline personality disorder.

Authors:  Y Pritham Raj
Journal:  Curr Psychiatry Rep       Date:  2004-06       Impact factor: 5.285

Review 3.  The latest neuroimaging findings in borderline personality disorder.

Authors:  Jana Mauchnik; Christian Schmahl
Journal:  Curr Psychiatry Rep       Date:  2010-02       Impact factor: 5.285

Review 4.  State of the art in the pharmacologic treatment of borderline personality disorder.

Authors:  Louis Feurino; Kenneth R Silk
Journal:  Curr Psychiatry Rep       Date:  2011-02       Impact factor: 5.285

Review 5.  Borderline personality disorder.

Authors:  Joel Paris
Journal:  CMAJ       Date:  2005-06-07       Impact factor: 8.262

6.  Personality disorders begin in adolescence.

Authors:  Joel Paris
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2013-08

7.  Prediction of time-to-attainment of recovery for borderline patients followed prospectively for 16 years.

Authors:  M C Zanarini; F R Frankenburg; D B Reich; M M Wedig; L C Conkey; G M Fitzmaurice
Journal:  Acta Psychiatr Scand       Date:  2014-03-04       Impact factor: 6.392

8.  Levels of Acceptance and Forgiveness Reported by Patients With BPD and Personality-Disordered Comparison Subjects Over 20 Years of Prospective Follow-Up.

Authors:  Mary C Zanarini; Christina M Temes; Frances R Frankenburg; D Bradford Reich; Garrett M Fitzmaurice
Journal:  J Pers Disord       Date:  2019-01-16

9.  Borderline personality disorder: current drug treatments and future prospects.

Authors:  Bayanne Olabi; Jeremy Hall
Journal:  Ther Adv Chronic Dis       Date:  2010-03       Impact factor: 5.091

10.  Severity of anxiety symptoms reported by borderline patients and Axis II comparison subjects: description and prediction over 16 years of prospective follow-up.

Authors:  Mary C Zanarini; Frances R Frankenburg; Garrett M Fitzmaurice
Journal:  J Pers Disord       Date:  2014-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.